Dr Robert E Holmberg Jr, MD, MPH | |
110 Jones Point Rd, Brooksville, ME 04617-3570 | |
(207) 326-0916 | |
Not Available |
Full Name | Dr Robert E Holmberg Jr |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 110 Jones Point Rd, Brooksville, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457307852 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD9178 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert E Holmberg Jr, MD, MPH 110 Jones Point Rd, Brooksville, ME 04617-3570 Ph: (207) 326-0916 | Dr Robert E Holmberg Jr, MD, MPH 110 Jones Point Rd, Brooksville, ME 04617-3570 Ph: (207) 326-0916 |
News Archive
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for ACTEMRA® (tocilizumab) for the prevention of structural joint damage (as assessed by radiograph) and improvement in physical function in adults with moderately to severely active rheumatoid arthritis (RA).
Clarity Science, a division of Safe Harbor Compliance and Clinical Services LLC, report results of the Institutional Review Board- approved Optimizing Patient Experience and Response to Topical Analgesics Study which evaluated patients with chronic pain who were treated with topical analgesics.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.
In the largest multicenter clinical trial of children undergoing early-stage surgery for single-ventricle heart defects, differences in intraoperative management did not significantly affect neurodevelopmental outcomes at 14 months of age. Instead, the strongest influences were innate patient characteristics and general medical morbidity during the child's first year of life.
Treatment of obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) may also lower blood pressure among hypertensive adults, according to researchers in Spain, who will present his findings at the American Thoracic Society's 2008 International Conference in Toronto on Sunday, May 18.
› Verified 1 days ago